MD4484B1 - Forma cristalină VIII a agomelatinei, procedeu de preparare, utilizarea acesteia şi compoziţie farmaceutică care o conţine - Google Patents
Forma cristalină VIII a agomelatinei, procedeu de preparare, utilizarea acesteia şi compoziţie farmaceutică care o conţineInfo
- Publication number
- MD4484B1 MD4484B1 MDA20130074A MD20130074A MD4484B1 MD 4484 B1 MD4484 B1 MD 4484B1 MD A20130074 A MDA20130074 A MD A20130074A MD 20130074 A MD20130074 A MD 20130074A MD 4484 B1 MD4484 B1 MD 4484B1
- Authority
- MD
- Moldova
- Prior art keywords
- preparation
- agomelatine
- crystalline form
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Invenţia se referă la forma cristalină mixtă VIII a agomelatinei, procedeul de preparare, utilizarea acesteia şi la o compoziţie farmaceutică care o conţine.Această formă cristalină VIII a agomelatinei este stabilă şi posedă o reproductibilitate bună. În urma testelor de stabilitate s-a dovedit că forma dată este superioară formei cristaline VI. Ca urmare a acestui fapt, forma cristalină VIII din prezenta invenţie posedă avantaje în producere. Procedeul de preparare, conform invenţiei, include dizolvarea compusului agomelatinei în acid acetic, la care se adaugă acetat de sodiu, după care la acest amestec al reacţiei se adaugă apă prin picurare şi se agită la o temperatură cuprinsă între 7…13°C pentru a provoca cristalizarea, cristalele fiind apoi separate din soluţie.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100706340A CN102690209A (zh) | 2011-03-23 | 2011-03-23 | 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物 |
PCT/CN2012/072818 WO2012126386A1 (zh) | 2011-03-23 | 2012-03-22 | 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20130074A2 MD20130074A2 (ro) | 2014-03-31 |
MD4484B1 true MD4484B1 (ro) | 2017-05-31 |
MD4484C1 MD4484C1 (ro) | 2017-12-31 |
Family
ID=46855965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20130074A MD4484C1 (ro) | 2011-03-23 | 2012-03-22 | Forma cristalină VIII a agomelatinei, procedeu de preparare, utilizarea acesteia şi compoziţie farmaceutică care o conţine |
Country Status (30)
Country | Link |
---|---|
US (1) | US20140088197A1 (ro) |
EP (1) | EP2690088B1 (ro) |
JP (1) | JP6203171B2 (ro) |
KR (1) | KR20130136546A (ro) |
CN (2) | CN102690209A (ro) |
AR (1) | AR085915A1 (ro) |
AU (1) | AU2012231548B2 (ro) |
BR (1) | BR112013024022A2 (ro) |
CA (1) | CA2829690C (ro) |
CY (1) | CY1118751T1 (ro) |
DK (1) | DK2690088T3 (ro) |
EA (1) | EA023278B1 (ro) |
ES (1) | ES2626030T3 (ro) |
GE (1) | GEP201606567B (ro) |
HK (1) | HK1193086A1 (ro) |
HR (1) | HRP20170575T1 (ro) |
HU (1) | HUE034329T2 (ro) |
LT (1) | LT2690088T (ro) |
MA (1) | MA34959B1 (ro) |
MD (1) | MD4484C1 (ro) |
ME (1) | ME02731B (ro) |
MX (1) | MX355551B (ro) |
MY (1) | MY166444A (ro) |
PL (1) | PL2690088T3 (ro) |
PT (1) | PT2690088T (ro) |
RS (1) | RS55918B1 (ro) |
SG (1) | SG193305A1 (ro) |
SI (1) | SI2690088T1 (ro) |
WO (1) | WO2012126386A1 (ro) |
ZA (1) | ZA201306761B (ro) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH12012000132A1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
ME03741B (me) * | 2013-07-29 | 2021-04-20 | Shanghai Inst Pharmaceutical Ind | Konpleksi agomelatina i sulfonskih kisjelina, postupak njihove proizvodnje i proizvodnje farmaceutskih pripravaka koji ih sadržavaju |
CN104529804A (zh) * | 2014-12-11 | 2015-04-22 | 连云港金康医药科技有限公司 | 阿戈美拉汀的新晶型 |
EP3075724B1 (en) | 2015-03-31 | 2023-07-12 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Solid form of agomelatine |
EP3466923A1 (en) * | 2017-10-09 | 2019-04-10 | KRKA, d.d., Novo mesto | Process for the preparation of agomelatine in crystalline form |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US7498466B2 (en) * | 2004-02-13 | 2009-03-03 | Les Laboratoires Servier | Process for the synthesis and crystalline form of agomelatine |
FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
FR2889523B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2889522B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2889521B1 (fr) * | 2005-08-03 | 2007-12-28 | Servier Lab | Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2923482B1 (fr) * | 2007-11-09 | 2010-01-29 | Servier Lab | Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
CN101585779B (zh) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | 阿戈美拉汀的晶型vi及其制备方法和应用 |
WO2011006387A1 (zh) * | 2009-07-11 | 2011-01-20 | 浙江华海药业股份有限公司 | 阿戈美拉汀的制备方法、阿戈美拉汀晶形及其制备方法 |
CN101723844A (zh) * | 2009-11-21 | 2010-06-09 | 浙江华海药业股份有限公司 | 一种阿戈美拉汀晶形b、它的制备方法和包含它的药物组合物 |
CN101955440B (zh) * | 2009-07-17 | 2014-04-09 | 江苏万特制药有限公司 | 一种阿戈美拉汀新晶型及其制备方法 |
EP2319827A1 (en) * | 2009-11-09 | 2011-05-11 | Ratiopharm GmbH | Process for the production of polymorph form I of agomelatine |
CN101781226B (zh) * | 2009-12-23 | 2012-03-28 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀及其药物组合物 |
CN101792400B (zh) * | 2010-03-16 | 2013-01-30 | 华东师范大学 | 一种阿戈美拉汀的合成方法 |
WO2011154140A2 (en) * | 2010-06-10 | 2011-12-15 | Gador S.A. | New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide and new crystalline form |
WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
CN102452952A (zh) * | 2010-11-03 | 2012-05-16 | 天津药物研究院 | 一种高纯度的i型阿戈美拉汀晶体制备方法 |
-
2011
- 2011-03-23 CN CN2011100706340A patent/CN102690209A/zh active Pending
-
2012
- 2012-03-22 HU HUE12761142A patent/HUE034329T2/en unknown
- 2012-03-22 CA CA2829690A patent/CA2829690C/en not_active Expired - Fee Related
- 2012-03-22 JP JP2014500244A patent/JP6203171B2/ja not_active Expired - Fee Related
- 2012-03-22 US US14/006,484 patent/US20140088197A1/en not_active Abandoned
- 2012-03-22 BR BR112013024022A patent/BR112013024022A2/pt not_active Application Discontinuation
- 2012-03-22 LT LTEP12761142.4T patent/LT2690088T/lt unknown
- 2012-03-22 DK DK12761142.4T patent/DK2690088T3/en active
- 2012-03-22 MD MDA20130074A patent/MD4484C1/ro not_active IP Right Cessation
- 2012-03-22 SI SI201230949A patent/SI2690088T1/sl unknown
- 2012-03-22 SG SG2013066600A patent/SG193305A1/en unknown
- 2012-03-22 EP EP12761142.4A patent/EP2690088B1/en active Active
- 2012-03-22 PL PL12761142T patent/PL2690088T3/pl unknown
- 2012-03-22 EA EA201301065A patent/EA023278B1/ru not_active IP Right Cessation
- 2012-03-22 MX MX2013010634A patent/MX355551B/es active IP Right Grant
- 2012-03-22 MA MA36226A patent/MA34959B1/fr unknown
- 2012-03-22 GE GEAP201213264A patent/GEP201606567B/en unknown
- 2012-03-22 ES ES12761142.4T patent/ES2626030T3/es active Active
- 2012-03-22 PT PT127611424T patent/PT2690088T/pt unknown
- 2012-03-22 KR KR1020137027641A patent/KR20130136546A/ko not_active Application Discontinuation
- 2012-03-22 AU AU2012231548A patent/AU2012231548B2/en not_active Ceased
- 2012-03-22 RS RS20170307A patent/RS55918B1/sr unknown
- 2012-03-22 CN CN201280013429.3A patent/CN103476743B/zh active Active
- 2012-03-22 MY MYPI2013701574A patent/MY166444A/en unknown
- 2012-03-22 WO PCT/CN2012/072818 patent/WO2012126386A1/zh active Application Filing
- 2012-03-23 AR ARP120100969A patent/AR085915A1/es unknown
-
2013
- 2013-09-09 ZA ZA2013/06761A patent/ZA201306761B/en unknown
-
2014
- 2014-06-24 HK HK14106352.3A patent/HK1193086A1/xx not_active IP Right Cessation
-
2017
- 2017-03-20 CY CY20171100351T patent/CY1118751T1/el unknown
- 2017-04-11 HR HRP20170575TT patent/HRP20170575T1/hr unknown
- 2017-06-12 ME MEP-2017-109A patent/ME02731B/me unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD4391C1 (ro) | Formă cristalină nouă VII a agomelatinei, procedeu de preparare şi utilizarea acesteia, şi compoziţie farmaceutică care o conţine | |
MD4484C1 (ro) | Forma cristalină VIII a agomelatinei, procedeu de preparare, utilizarea acesteia şi compoziţie farmaceutică care o conţine | |
UA109774C2 (uk) | Кристалічні форми саксагліптину та процес його одержання (варіанти) | |
NZ619235A (en) | L-ornithine phenyl acetate and methods of making thereof | |
EA201590035A1 (ru) | Способ получения кондиционирующей композиции для волос | |
NZ609191A (en) | Methods of making l-ornithine phenyl acetate | |
BR112013011593A2 (pt) | cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo | |
BRPI0509595B8 (pt) | processos para a preparação de cristais de forma a e de material de padrão c de bissulfato de atazanavir | |
ES2647239T3 (es) | Proceso para producir cristales de ácido polimórfico 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico mediante método de adición de solvente pobre | |
EA201990688A1 (ru) | Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение | |
NZ600263A (en) | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof | |
MX2015011627A (es) | Cristales de laquinimod sodico y proceso mejorado para la elaboracion de los mismos. | |
MD4350B1 (ro) | Forma cristalină delta a sării de L-arginină a perindoprilului, procedeu de obţinere a ei şi compoziţii farmaceutice care o conţin | |
ES2366240T3 (es) | Biarilcarboxiarilamidas como moduladores del receptor vanilloide-1. | |
DK1940772T3 (da) | Ny fremgangsmåde til fremstilling af kvaternære syre- og ammoniumsalte | |
AR089078A1 (es) | Formas cristalinas de [(s)-1-carbamoil-2-(fenil-pirimidin-2-il-amino)-etil]-amida de acido 2-(2-metilamino-pirimidin-4-il)-1h-indol-5-carboxilico | |
AR074885A1 (es) | Metodo para purificar 4-(nitrooxi)butil (2s)-2-(6-metoxi-2-naftil)propanoato | |
EA201200241A1 (ru) | Новая кристаллическая форма органического соединения и способ её получения | |
TR201101897A2 (tr) | Tiotropyum bromür içeren kristal madde | |
RU2014129930A (ru) | Иминосахар в кристаллической форме | |
RU2508286C1 (ru) | Способ получения 4,6-динитро-о-крезола | |
IN2013DE00241A (ro) | ||
UA64050U (ru) | Способ получения двойного триортофосфата калия-железа (iii) | |
CN105218520A (zh) | 一种埃索美拉唑镁结晶二水合物的制备方法 | |
UA64049U (ru) | Способ получения ортофосфата железа (iii) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |